{'text': 'Stock buybacks enrich executive pay even when business sags', 'publisher': {'href': 'http://www.reuters.com', 'title': 'Reuters'}, 'created_at': 'Thu, 10 Dec 2015 08:00:00 GMT', 'description': 'Stock buybacks enrich executive pay even when business sags  Reuters', 'url': 'https://news.google.com/rss/articles/CBMid0FVX3lxTE5vX0d4VEg1QnM2a2d5Q1duSmRkVFREN21RdDVpUFNRclNjYW5MeXU0ZVFSQlh5ZGItaEI3UXBTOFotWWhXNVlNWHVUd1RxaHpob0s0aGcwMGxLdnc4Vk1JNXI4ZEFJMWFXeFJGQUV4WXpYMGlBcUxz?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'The new PCSK9 scorecard: Praluent favored by UnitedHealth, Repatha by CVS, both by Express Scripts', 'publisher': {'href': 'https://www.biopharmadive.com', 'title': 'BioPharma Dive'}, 'created_at': 'Fri, 11 Dec 2015 08:00:00 GMT', 'description': 'The new PCSK9 scorecard: Praluent favored by UnitedHealth, Repatha by CVS, both by Express Scripts  BioPharma Dive', 'url': 'https://news.google.com/rss/articles/CBMitAFBVV95cUxQQV9scGdsRFhvSHEzZnJuRVI5Nll3dTRYV01aTy1uc053LU1TTTYtS0k4VGhoenBTWHVneUNyS1V1VkJCMWw4X0Y5VUoxcElyb1ZzTmRtaFBtWDU4OFlXRjBOMno3TTJoQWFRRnpiblpoc0FJTEVFT1FkTi1UNTh4Mm5nNzV5RjVEQ1hrVWZqVlpoN1pJT2JfbGFmbXphaEFkWVlnYk9RR2hTZlZ2bVJHSXJ2VEI?oc=5&hl=en-US&gl=US&ceid=US:en'}
